NovoCure (NVCR) Gross Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.00 |
| Dec 31, 2025 | 257.00 |
| Sep 30, 2025 | -64.00 |
| Jun 30, 2025 | -126.00 |
| Mar 31, 2025 | -410.00 |
| Dec 31, 2024 | 205.00 |
| Sep 30, 2024 | 24.00 |
| Jun 30, 2024 | 128.00 |
| Mar 31, 2024 | 1.00 |
| Dec 31, 2023 | 87.00 |
| Sep 30, 2023 | 178.00 |
| Jun 30, 2023 | -275.00 |
| Mar 31, 2023 | -174.00 |
| Dec 31, 2022 | 22.00 |
| Sep 30, 2022 | -248.00 |
| Jun 30, 2022 | -8.00 |
| Mar 31, 2022 | 213.00 |
| Dec 31, 2021 | 32.00 |
| Sep 30, 2021 | -119.00 |
| Jun 30, 2021 | -183.00 |
| Mar 31, 2021 | -4.00 |
| Dec 31, 2020 | 186.00 |
| Sep 30, 2020 | 57.00 |
| Jun 30, 2020 | 208.00 |
| Mar 31, 2020 | 92.00 |
| Dec 31, 2019 | -10.00 |
| Sep 30, 2019 | -53.00 |
| Jun 30, 2019 | 269.00 |
| Mar 31, 2019 | 602.00 |
| Dec 31, 2018 | -379.00 |
| Sep 30, 2018 | 298.00 |
| Jun 30, 2018 | 275.00 |
| Mar 31, 2018 | -584.00 |
| Dec 31, 2017 | 109.00 |
| Sep 30, 2017 | 403.00 |
| Jun 30, 2017 | -83.00 |
| Mar 31, 2017 | 285.00 |
| Dec 31, 2016 | 1,501.00 |
| Sep 30, 2016 | 3,916.00 |
| Jun 30, 2016 | -2,931.00 |
| Mar 31, 2016 | -1,024.00 |
| Dec 31, 2015 | 1,230.00 |
| Sep 30, 2015 | 939.00 |
| Jun 30, 2015 | 223.00 |
| Mar 31, 2015 | -563.00 |
| Dec 31, 2014 | -1,007.00 |